Accolade, Inc. Reiterates Revenue Guidance for Fiscal Fourth Quarter Ending February 28, 2023 and Fiscal Year Ending February 29, 2024
February 28, 2023 at 05:02 pm EST
Share
Accolade, Inc. reiterated revenue guidance for fiscal fourth quarter ending February 28, 2023 and fiscal year ending February 29, 2024. Reiterated guidance for the fiscal fourth quarter ending February 28, 2023 of revenue between $97 million and $101 million.
Reiterated revenue guidance for the fiscal year ending February 29, 2024 of approximately $410 million.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
